SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-024707
Filing Date
2019-11-26
Accepted
2019-11-26 14:19:04
Documents
4
Period of Report
2019-11-26

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k112619_biondvaxpharma.htm 6-K 11925
2 PRESS RELEASE DATED NOVEMBER 26, 2019 f6k112619ex99-1_biondvax.htm EX-99.1 83465
3 BIONDVAX PHARMACEUTICALS LTD. UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDI f6k112619ex99-2_biondvax.htm EX-99.2 323798
4 GRAPHIC ex99-1_001.jpg GRAPHIC 13111
  Complete submission text file 0001213900-19-024707.txt   438378
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 191249752
SIC: 2836 Biological Products, (No Diagnostic Substances)